Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Peter C. Black, H.A.D.M. Ashab et al.|European Urology|2017Cited by 793
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Peter C. Black, Ewan A. Gibb et al.|Clinical Cancer Research|2018Cited by 126
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J. de Jong, Ewan A. Gibb, Yang Liu et al.|Genome Medicine|2019Cited by 102
Increased <scp> <i>MYBL2</i> </scp> expression in aggressive hormone‐sensitive prostate cancerYuki Yoshikawa, Christopher J. Sweeney, Rahim Hirani et al.|Molecular Oncology|2022Cited by 17